We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Tests Predicts the Risk of Liver Cirrhosis

By LabMedica International staff writers
Posted on 15 Jul 2020
Fat accumulation in the liver is common and is often seen in people with obesity or diabetes. More...
In the worst case, fatty liver can lead to cirrhosis or liver cancer. It is unusual for this to occur but in those affected, symptoms often only occur at a late stage when there is no available treatment.

The gold standard for diagnosing fibrosis is liver biopsy, which is not reasonable to use as a screening tool in larger populations, expressly in a general population or primary care setting. Several non-invasive scores have been developed to identify individuals with prevalent advanced fibrosis. The Fibrosis-4 (FIB-4) scoring system is often used to estimate the risk of advanced fibrosis in liver diseases.

Hepatology Specialists at the Karolinska University Hospital (Stockholm, Sweden) and their colleagues tested the general hypothesis that repeated measurements of the commonly used FIB-4 index (FIB-4) would improve the identification of individuals at risk of severe liver disease compared with a single measurement. The investigators used the AMORIS cohort that contains laboratory test data in a very large population, surveyed between 1985 and 1996. More than 40,000 people had blood test data for FIB-4 from several sampling occasions. They were followed in national registers to identify those who developed cirrhosis after up to 27 years.

All laboratory analyses were conducted on fresh blood serum samples (53% after overnight fasting) using a uniform and well-documented methodology. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were determined with an enzymatic UV test and Gamma-glutamyltransferase (GGT) by an enzymatic colorimetric test using a Technicon DAX 96 Multichannel Analyzer (Technicon Instruments Corp., Tarrytown, NY, USA). Glucose levels were analyzed with an enzyme colorimetric technique (glucose oxidase/peroxidase, GOD-PAP) using an AutoChemist-PRISMA automated multichannel analyzers (New Clinicon, Stockholm, Sweden).

The scientists reported that an increase of one unit in FIB-4 was associated with an elevated risk of severe liver disease (adjusted Hazard ratio [aHR] = 1.81). Transitioning from a low- or intermediate- to a high-risk group was associated with an increased risk of severe liver disease compared with those consistently in the low-risk group (aHR = 7.99 and 8.64, respectively). A particularly increased risk of severe liver disease was found in persons defined as high-risk at both tests (aHR=17.04). However, almost half of all events occurred in those consistently in the low-risk group.

Hannes Hagström, MD, PhD, a Consultant in Hepatology and lead author of the study, said, “It is difficult to predict the risk of cirrhosis, although you can get some guidance in using regular blood tests that measure liver damage. We showed that this biomarker is useful for identifying people in primary care with an increased risk of cirrhosis who may need to be more carefully investigated and to exclude people who do not need this. But the method needs to be further developed to reduce the risk of false positive findings, which can lead to unnecessary examinations in healthy people.”

The authors concluded that repeated testing of FIB-4 within five years improves the identification of individuals in the general population at an increased risk of severe liver disease. The study was published on July 1, 2020 in the Journal of Hepatology.

Related Links:
Karolinska University Hospital
Technicon Instruments Corp
New Clinicon



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Pneumoniae Test
Chlamydia Pneumoniae (CP) Real Time PCR Kit
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: This image shows a second-generation version of the device that can also measure cell morphology (Photo courtesy of MIT)

Rapid Cell Density Measurement Technique to Help Predict Immunotherapy Response

The density of a cell provides valuable insights into its condition. As cells go through processes such as proliferation, differentiation, or cell death, they may gain or lose water and other molecules,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.